21 Days head-down bed rest induces weakening of cell-mediated immunity - Some spaceflight findings confirmed in a ground-based analog

Cytokine

Volumn 59, Issue 2, 2012, Pages 403-409

  Kelsen, Jens ^a   Bartels, Lars Erik ^b   Dige, Anders ^b   Hvas, Christian Lodberg ^b   Frings Meuthen, Petra ^c   Boehme, Gisela ^c   Thomsen, Marianne Kragh ^b   Fenger Grøn, Morten ^d   Dahlerup, Jens Frederik ^b  

^a RANDERS REGIONAL HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c GERMAN AEROSPACE CENTER DLR   (Germany)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

Bed rest; CMV QuantiFERON; Microgravity; T cells

Indexed keywords

ANTIBIOTIC AGENT; CANDIDA ANTIGEN; CD4 ANTIGEN; CLINDAMYCIN; FUNGICIDE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; PHYTOHEMAGGLUTININ; POTASSIUM BICARBONATE; T LYMPHOCYTE ANTIGEN; TETANUS TOXOID; TRANSCRIPTION FACTOR FOXP3; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; BED REST; BLOOD SAMPLING; BONE DEMINERALIZATION; BRAIN ABSCESS; CANDIDA ALBICANS; CD4+ CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; CYTOMEGALOVIRUS; DENDRITIC CELL; DIET SUPPLEMENTATION; DOWN REGULATION; EPSTEIN BARR VIRUS; EXTERNAL OTITIS; FLOW CYTOMETRY; GAMMA DELTA T LYMPHOCYTE; HEAD DOWN BED REST; HEAD POSITION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOMODULATION; INTERFERON PRODUCTION; MALE; MICROGRAVITY; NATURAL KILLER CELL; NORMAL HUMAN; PERIODONTITIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPACE FLIGHT; T LYMPHOCYTE ACTIVATION; TH1 TH2 BALANCE; TH2 CELL; THERAPY EFFECT; TINEA PEDIS; VIRUS IMMUNITY; VIRUS REACTIVATION;

ADULT; BED REST; COMMUNICABLE DISEASES; CROSS-OVER STUDIES; CYTOKINES; EPITOPES; FLOW CYTOMETRY; GERMANY; HEAD-DOWN TILT; HUMANS; IMMUNITY, CELLULAR; INCIDENCE; MALE; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; PHYTOHEMAGGLUTININS; REPRODUCIBILITY OF RESULTS; SPACE FLIGHT; T-LYMPHOCYTES; TIME FACTORS; VIRUSES; WEIGHTLESSNESS COUNTERMEASURES; WEIGHTLESSNESS SIMULATION;

CANDIDA ALBICANS; CYTOMEGALOVIRUS; HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 84862322182     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.04.032     Document Type: Article

References (29)

1. Gmunder F.K., Konstantinova I., Cogoli A., Lesnyak A., Bogomolov W., et al. Cellular immunity in cosmonauts during long duration spaceflight on board the orbital MIR station. Aviat Space Environ Med 1994, 65:419-423.
2. Taylor G.R., Janney R.P. In vivo testing confirms a blunting of the human cell-mediated immune mechanism during space flight. J Leukoc Biol 1992, 51:129-132.
3. Cogoli A. The effect of space flight on human cellular immunity. Environ Med 1993, 37:107-116.
4. Baqai F.P., Gridley D.S., Slater J.M., Luo-Owen X., Stodieck L.S., et al. Effects of spaceflight on innate immune function and antioxidant gene expression. J Appl Physiol 2009, 106:1935-1942.
5. Gridley D.S., Slater J.M., Luo-Owen X., Rizvi A., Chapes S.K., et al. Spaceflight effects on T lymphocyte distribution, function and gene expression. J Appl Physiol 2009, 106:194-202.
6. Lewis M.L., Cubano L.A., Zhao B., Dinh H.K., Pabalan J.G., et al. cDNA microarray reveals altered cytoskeletal gene expression in space-flown leukemic T lymphocytes (Jurkat). FASEB J 2001, 15:1783-1785.
7. Wilson J.W., Ott C.M., Honer zu B.K., Ramamurthy R., Quick L., et al. Space flight alters bacterial gene expression and virulence and reveals a role for global regulator Hfq. Proc Natl Acad Sci USA 2007, 104:16299-16304.
8. Gueguinou N., Huin-Schohn C., Bascove M., Bueb J.L., Tschirhart E., et al. Could spaceflight-associated immune system weakening preclude the expansion of human presence beyond Earth's orbit?. J Leukoc Biol 2009, 86:1027-1038.
9. Crucian B.E., Stowe R.P., Pierson D.L., Sams C.F. Immune system dysregulation following short- vs long-duration spaceflight. Aviat Space Environ Med 2008, 79:835-843.
10. Crucian B.E., Cubbage M.L., Sams C.F. Altered cytokine production by specific human peripheral blood cell subsets immediately following space flight. J Interferon Cytokine Res 2000, 20:547-556.
11. + T-cell contraction during pathogen challenge. Immunol Rev 2010, 236:110-124.
12. Mehta S.K., Stowe R.P., Feiveson A.H., Tyring S.K., Pierson D.L. Reactivation and shedding of cytomegalovirus in astronauts during spaceflight. J Infect Dis 2000, 182:1761-1764.
13. Crucian B.E., Stowe R.P., Ott C.M., Becker J.L., Haddon R., McMonigal K.A., et al. Risk of crew adverse health event due to altered immune response. Human research program. Human health countermeasures element. National Aeronautics and Space Administration (NASA) 2009.
14. Schmitt D.A., Schaffar L., Taylor G.R., Loftin K.C., Schneider V.S., et al. Use of bed rest and head-down tilt to simulate spaceflight-induce immune system changes. J Interferon Cytokine Res 1996, 16:151-157.
15. Yang C.B., Wang Y.C., Gao Y., Geng J., Wu Y.H., et al. Artificial gravity with ergometric exercise preserves the cardiac but not cerebrovascular functions during 4days of head-down bed rest. Cytokine 2011, 56:648-655.
16. Crucian B.E., Stowe R.P., Mehta S.K., Yetman D.L., Leal M.J., et al. Immune status, latent, viral reactivation, and stress during long-duration head-down bed rest. Aviat Space Environ Med 2009, 80:A37-A44.
17. Shearer W.T., Ochs H.D., Lee B.N., Cohen E.N., Reuben J.M., et al. Immune responses in adult female volunteers during the bed-rest model of spaceflight: antibodies and cytokines. J Allergy Clin Immunol 2009, 123:900-905.
18. + T-cell responses using QuantiFERON-CMV. Transpl Infect Dis 2007, 9:165-170.
19. Kumar D., Chernenko S., Moussa G., Cobos I., Manuel O., et al. Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients. Am J Transplant 2009, 9:1214-1222.
20. Beetz S., Wesch D., Marischen L., Welte S., Oberg H.H., et al. Innate immune functions of human gammadelta T cells. Immunobiology 2008, 213:173-182.
21. Hvas C.L., Kelsen J., Agnholt J., Dige A., Christensen L.A., et al. Discrete changes in circulating regulatory T cells during infliximab treatment of Crohn's disease. Autoimmunity 2010, 43:325-333.
22. van Doornum G.J., Guldemeester J., Osterhaus A.D., Niesters H.G. Diagnosing herpesvirus infections by real-time amplification and rapid culture. J Clin Microbiol 2003, 41:576-580.
23. Kelsen J., Dige A., Schwindt H., D'Amore F., Pedersen F.S., et al. Infliximab induces clonal expansion of gammadelta-T cells in Crohn's disease: a predictor of lymphoma risk?. PLoS One 2011, 6:e17890.
24. Schmitt D.A., Schwarzenberg M., Tkaczuk J., Hebrard S., Brandenberger G., et al. Head-down tilt bed rest and immune responses. Pflugers Arch 2000, 441:R79-R84.
25. De G.D., Zangerle P.F., Gevaert Y., Fassotte M.F., Beguin Y., et al. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I Comparison with isolated PBMC stimulation. Cytokine 1992, 4:239-248.
26. Petrovsky N., Harrison L.C. Cytokine-based human whole blood assay for the detection of antigen-reactive T cells. J Immunol Methods 1995, 186:37-46.
27. + T reg cells. J Exp Med 2006, 203:1701-1711.
28. Elkord E. Frequency of human T regulatory cells in peripheral blood is significantly reduced by cryopreservation. J Immunol Methods 2009, 347:87-90.
29. Weinberg A., Song L.Y., Wilkening C., Sevin A., Blais B., et al. Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization. Clin Vaccine Immunol 2009, 16:1176-1186.